Bibiliografía

1. Sun Y, Wu X. Complications of implanted port catheters and peripherally inserted central catheters in chemotherapy-treated cancer patients: A meta-analysis. Adv Clin Exp Med. 2023 May;32(5):523-32. [PubMed]

2. Chopra V, Kaatz S, Conlon A, et al. The Michigan Risk Score to predict Peripherally Inserted Central Catheter-Associated Thrombosis. J Thromb Haemost. 2017;10:1951-62. [PubMed]

3. Leung A, Heal C, Perera M, et al. A systematic review of patient-related risk factors for catheter-related thrombosis. J Thromb Thrombolysis. 2015;40:363-73. [PubMed]

4. Smith SN, Moureau N, Vaughn VM, et al. Patterns and predictors of peripherally inserted central catheter occlusion: The 3P-O study. J Vasc Interv Radiol. 2017;28: 749-56. [PubMed]

5. Simonetti G, Bersani A, Tramacere I, Lusignani M, Gaviani P, Silvani A. The role of body mass index in the development of thromboembolic events among cancer patients with PICCs: a systematic review. J Vasc Nurs. 2022 Mar;40(1):11-6. [PubMed]

6. Liang YJ, Tang LQ, Sun XS, Fan YY, Yan JJ, Du YY, et al. Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis. BMC Cancer. 2018 Dec 29;18(1):1297. [PubMed]

7. Kang J, Sun W, Li H, Ma E, Wang K, Chen W. Peripherally inserted central catheter-related vein thrombosis in breast cancer patients. J Vasc Access. 2016 Jan-Feb;17(1):67-71. [PubMed]

8. Ma S, Shen C, Li Q, Yang H, Hu Y, Wei X, Liang T. Clinical factors of PICC-RVT in cancer patients: a meta-analysis. Support Care Cancer. 2023 Jun 14;31(7):393. [PubMed]

9. Decousus H, Bourmaud A, Fournel P, Bertoletti L, Labruyère C, Presles E, Merah A, et al.; ONCOCIP Investigators. Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP). Blood. 2018 Aug 16;132(7):707-716. [PubMed]

10. D’Ambrosio L, Aglietta M, Grignani G. Anticoagulation for central venous catheters in patients with cancer. N Engl J Med. 2014;371:1362-3. [PubMed]

11. Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev. 2018 Jun 1;6(6):CD006468. [PubMed]

12. Ikesaka R, Siegal D, Mallick R, Wang TF, Witham D, Webb C, Carrier M; Canadian Venous Thromboembolism Research Network (CanVECTOR). Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): a two-center open-label pilot randomized controlled trial. Res Pract Thromb Haemost. 2021 May 5;5(4):e12517. PMID: 34027291.

13. Monreal M, Raventos A, Lerma R, et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines: A prospective study. Thromb Haemost. 1994;72:548-50. [PubMed]

14. Baumann Kreiziger L, Onwuemene O, Kolesar E, et al. Systematic review of anticoagulant treatment of catheter-related thrombosis. Thromb Res. 2015;136: 1103-9. [PubMed]

15. Elman EE, Kahn SR. The posthrombotic síndrome after upper extremity deep vein thrombosis in adults: a systematic review. Thromb Res. 2006;117:609-14. [PubMed]

16. Baskin JL, Reiss U, Wilimas JA, et al. Thrombolytic therapy for central venous catheter occlusion. Haematologica. 2012;97:641-50. [PubMed]

17. van Miert C, Hill R, Jones L. Interventions for restoring patency of occluded central venous catheter lumens. Cochrane Database Syst Rev. 2012;Apr18 (4):CD007119. [PubMed]

18. Mulder FI, Bosch FTM, Young AM, Marshall A, McBane RD, Zemla TJ, et al. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis. Blood. 2020 Sep 17;136(12):1433-41. [PubMed]

19. Davies GA, Lazo-Langner A, Gandara E, Rodger M, Tagalakis V, Louzada M, Corpuz R, Kovacs MJ. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2). Thromb Res. 2018 Feb;162:88-92. [PubMed]

20. Laguna JC, Cooksley T, Ahn S, Tsoukalas N, Oo TH, Brito-Dellan N, et al.; MASCC Hemostasis Study Group. Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care. Support Care Cancer. 2022 Oct;30(10):8577-88. [PubMed]

21. Wang TF, Kou R, Carrier M, Delluc A. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis. J Thromb Haemost. 2024 Mar;22(3):749-64. [PubMed]

Links de interés

  • Página web educativa específica para catéteres venosos centrales CATHMatters:[Enlace]
  • Página web del Group Francophone Thrombose et Cancer(GFTC): [Enlace]
  • Página web del Journal of Clinical Oncologycon las guías clínicas de manejo de las complicaciones asociadas a catéter (2013) de la American Society of Clinical Oncology(ASCO): [Enlace]
  • Página web del Journal of Thrombosis and Hemostasis con acceso libre a la guía clínica de la International Society of Thrombosis and Hemostasis (ISTH) de 2013: [Enlace]
  • Página web del Journal of Thrombosis and Hemostasis con acceso libre a la guía clínica de manejo de trombosis asociada a catéter de 2014: [Enlace]
  • Programa educacional en la página web de la American Society of Hematology (ASH) con libre acceso a un artículo de revisión en Hematology (2014) sobre trombosis asociada a catéter: [Enlace]
  • Página web de la European Society of Medical Oncology (ESMO) con acceso libre la guía clínica de infección y trombosis de catéter (2015): [Enlace]
  • Página web de la National Comprehensive Cancer Network (NCCN)con diversas guías clínicas para tratamiento de soporte al paciente oncológico, acceso no libre: [Enlace]
  • Página web del movimiento internacional The Global World Thrombosis Day Movementcon acceso a mucha información, recursos y otros enlaces de interés: [Enlace]
  • Página web de Anticoagulation Europe con información de interés para pacientes y profesionales: [Enlace]